Galectin Therapeutics | GALT - Aktiva

Keuangan

USD

USD 27.66M

USD 25.6M

USD 27.29M

Kewajiban Lancar

USD 14.62M

USD 71.74M

Dividen - Hasil

0

USD -9.17M

USD -7.43M

14

Eps Laba Per Saham

USD -0.2

Modal Dan Cadangan

USD -83.87M

Beban Bunga Utang

USD 1.27M

Pendapatan Bunga

USD -2.71M

USD 93.42M

Kapitalisasi Pasar

USD 225.6M

Batas Pemasukan

USD -12.37M

Biaya Operasional

USD 11.29M

Laba Operasional

USD -11.29M

Modal Saham Biasa

USD 61K

Laba Sebelum Pajak

USD -12.37M

Pendapatan Penjualan

4.02

Beban Penjualan Dan Administrasi

USD 1.48M

Kreditur Perdagangan

USD 3.7M

	Aktiva	Perubahan		Tanggal
AbbVie	USD 135.12B		1.35B	2026-06
Bristol-Myers Squibb	USD 87.63B		1.16B	2026-06
Galectin Therapeutics	USD 27.65M		1.76M	2024-06
Gilead Sciences	USD 49.36B		6.92B	2026-06
Immunic	USD 189.74M		165.69M	2026-03
Incyte	USD 7.87B		533.53M	2026-06
Merck	USD 129.8B		1.12B	2026-06